The Weight is Over: Time to Address Obesity in Type 2 Diabetes Management
Released On
March 25, 2024
Expires On
March 25, 2025
Media Type
Internet
Completion Time
60 minutes
Specialty
Diabetes/Obesity
Topics
Diabetes, Obesity
This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Lilly.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 ANCC contact hour
Target Audience
This educational activity is intended for US primary care physicians, physician assistants, and nurse practitioners who treat patients with T2DM and obesity.
Program Overview
This virtual activity is designed to help clinicians simultaneously address weight management and glycemic control in patients with type 2 diabetes (T2DM). Along with didactic instruction, the activity will include small group case-study discussions to provide practice in identifying and treating patients who would benefit from a weight-centric approach to type 2 diabetes management, ultimately improving outcomes of patients affected by this complex, chronic disease.
Learning Objectives
- Intensify or change therapy according to guidelines when patients with T2DM fail to meet their weight management and/or glycemic goals
- Integrate weight loss into treatment strategies for patients with type 2 diabetes and obesity/overweight using up-to-date guidelines
- Apply clinical data on incretin-based therapies that facilitate both weight management and glycemic control
- Utilize shared decision-making when selecting treatments for patients with type 2 diabetes based on patients’ values, preferences and personal contexts
Faculty
Neil Skolnik, M.D.
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Jefferson Health
Abington, Pennsylvania
Accreditation Statement
Joint Accreditation Statement
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nurses (ANCC) Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosures of Financial Relationships
- Neil Skolnik, M.D.
- Consulting Fees: AstraZeneca, Teva, Lilly, Boehringer Ingelheim, Sanofi, Sanofi Pasteur, GlaxoSmithKline, Bayer, Genetch, Abbot, Idorsia, Novartis, Novo Nordisk, Astellas
- Speakers Bureau: AstraZeneca; Boehringer Ingelheim; Lilly, GlaxoSmithKline, Teva, Bayer, Heartland, Astellas
- Contracted Research: AstraZeneca, GlaxoSmithKline, Novo Nordisk, Novartis
All relevant financial relationships have been mitigated.
Instructions for Participation and Credit
Method of Participation
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact Med Learning Group at: [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Content - Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
